Physician profile
Wayne P Daigle
NPI 1669434189
$1,822.64
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $548 · 2020: $274 · 2021: $423 · 2022: $356 · 2023: $205 · 2024: $17.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $222.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $289.25 | 2019-2022 | |
| Hologic Sales and Service, LLC | $153.71 | 2019-2023 | Aptima |
| Acclarent, INC | $149.09 | 2023 | Spine & Trauma 3d Navigation |
| Avion Pharmaceuticals | $129.89 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $128.90 | 2019 | |
| Pfizer INC. | $123.27 | 2019-2022 | |
| Therapeuticsmd, INC. | $88.88 | 2019-2022 | |
| Exeltis, USA INC. | $78.96 | 2019-2022 | |
| Astellas Pharma US INC | $63.95 | 2022-2024 | Veozah |
| Myovant Sciences INC. | $62.61 | 2021 | |
| Mayne Pharma Commercial LLC | $61.21 | 2021-2022 | |
| Lupin INC. | $54.69 | 2020 | |
| Biom'Up France Sas | $49.05 | 2021 | |
| Millicent US INC | $37.48 | 2020-2021 | |
| Ethicon US, LLC | $36.29 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $33.25 | 2021-2022 | |
| Minerva Surgical, INC | $29.78 | 2019-2021 | |
| Medtronic, INC. | $28.81 | 2022 | |
| Daiichi Sankyo INC. | $27.32 | 2019-2020 | |
| Coopersurgical, INC. | $25.85 | 2021-2022 | |
| Medicem INC. | $25.26 | 2020 | |
| Amgen INC. | $25.10 | 2019 | |
| Mylan Pharmaceuticals INC. | $19.44 | 2020 | |
| Sage Therapeutics, LLC | $17.91 | 2022 | |
| Merck Sharp & Dohme LLC | $16.37 | 2019 | |
| Allergan, INC. | $14.21 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.91 | 2019 | |
| Currax Pharmaceuticals LLC | $13.56 | 2019 | |
| Vertical Pharmaceuticals, LLC | $12.37 | 2019 | |
| Ferring Pharmaceuticals INC. | $12.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Daigle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.